Furthermore, the expression levels of p190RhoGAP are emerged as a prognostic factor in patients with skin cancer and moreover, promising therapeutic strategies are paved for potential targeted therapies against p190RhoGAP which indirectly will suppress ATX in cancer cells. The gene discussed is ARHGAP35; the disease is cancer.